Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cerner Corporation    CERN

CERNER CORPORATION

(CERN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Cerner : Duke Clinical Research Institute Launch New Solution to Innovate Clinical Research

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/06/2019 | 09:02am EDT

KANSAS CITY, Mo., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health platform and innovation company, has announced the development of the Cerner Learning Health NetworkSM to help clinicians more easily and efficiently gain health insights and guide care. Cerner aims to automate data collection from multiple sources, including the electronic health record (EHR), to rapidly give medical researchers access to important information that has the potential to transform patient care. Through combined technology and expertise, Cerner and the Duke Clinical Research Institute (DCRI) have joined together to pilot the Cerner Learning Health Network and innovate clinical research registries in the process.

The pilot project and study, named the Learning Registry by the DCRI, will use the Cerner Learning Health Network to evaluate the use and potential impact of proven therapies for chronic cardiovascular disease. Cerner and the DCRI aim to bring together data and intelligence to deliver clinicians insights on chronic cardiovascular disease, which if not treated properly can lead to heart disease and stroke. In the pilot project, the DCRI will use Cerner technology to analyze de-identified patient data from the University of Missouri Health Care and Ascension Seton, in partnership with Dell Medical School at The University of Texas at Austin, with the goal of finding the most effective treatment options.

“Collaborating with the DCRI on the Learning Registry to pilot the Cerner Learning Health Network is an exciting step forward in improving the health of those living with chronic cardiovascular disease,” said Art Glasgow, senior vice president, Strategic Growth, Cerner. “At Cerner, we’re committed to taking four decades of digitized data and transforming it into insights that can help clinicians make more informed treatment decisions. We have an opportunity to use clinical research and data-driven insights to develop an intelligent network of health systems that can truly improve health experiences and outcomes for patients.”

After the pilot project and study are complete, the Cerner Learning Health Network is expected to have wide-reaching applications in life sciences, pharmaceuticals and health care at large. The automation and streamlining of health data for clinical research has the potential to speed innovation and life-saving insights. More research on populations’ health gives clinicians additional tools to identify and treat a myriad of diseases and health concerns.

Clients will be able to leverage HealtheDataLabTM with the Cerner Learning Health Network to aggregate de-identified patient data from both Cerner and non-Cerner EHRs. HealtheDataLab is a ground-breaking tool that leverages the capabilities of HealtheIntent®, Cerner’s big data and insights platform for population health management. Researchers can use HealtheDataLab to take de-identified patient data, transform the data sets into research-ready formats and build complex models and algorithms to give providers more information to make more informed care decisions. By using predictive modeling and intelligence, the platform supports early identification of individuals who may be at risk for costly episodes of care and can help pinpoint the most effective and cost-efficient treatment options.

“Current models for clinical research and registries that rely on mostly manual chart abstraction are too expensive, too slow and too small to continue. We have to figure out better ways to leverage existing electronic resources to transform how we do clinical research,” said Dr. Ann Marie Navar, principal investigator and cardiovascular prevention researcher, the DCRI. “The EHR is an obvious starting point and HealtheIntent has all the right ingredients. It incorporates data from multiple EHRs, can link to national mortality and claims databases and helps us to harness the power and information security of cloud computing.”

The DCRI plans to publish the research results from the pilot project in a study sponsored by Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, with several products used to treat and prevent cardiovascular disease.

About Cerner

Cerner’s health technologies connect people and information systems at more than 27,500 contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog or connect on Facebook, Instagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You.

About the Duke Clinical Research Institute

The DCRI is the largest academic research organization in the world, with a mission to develop and share knowledge that improves the care of patients through innovative clinical research. The DCRI conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.

Media Contacts:

Cerner
Austin Cozzolino, Public Relations, (816) 786-2154, austin.cozzolino@cerner.com

The Duke Clinical Research Institute
Kaitlin Jansen, Strategic Communications, (919) 668-9223, kaitlin.jansen@duke.edu

Cerner_RGB_Standard_ horizontal.png

Source: Cerner Corporation

2019 GlobeNewswire, Inc., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CERNER CORPORATION
10/10Cerner to Release Third Quarter 2019 Earnings Results October 24
GL
10/08CERNER : CEO Unveils Next-Generation Cognitive Platform in Health Conference Key..
AQ
10/07Cerner and ResMed Join Forces to Connect Health Networks and the Home
GL
10/03Cerner and i2i Population Health Collaborate to Better Serve Medicaid Populat..
GL
09/24CERNER : and GetWellNetwork Bring More Convenience and Accessibility to Health C..
AQ
09/24CERNER : BayCare Health System to Present on Improved Pharmacy Operations Using ..
AQ
09/24CERNER CORPORATION : Ex-dividend day for
FA
09/16CERNER : Announces New Chief Marketing Officer
AQ
09/11CERNER CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/11Cerner Declares Quarterly Dividend
GL
More news
Financials (USD)
Sales 2019 5 715 M
EBIT 2019 1 057 M
Net income 2019 665 M
Debt 2019 407 M
Yield 2019 -
P/E ratio 2019 32,8x
P/E ratio 2020 24,4x
EV / Sales2019 3,84x
EV / Sales2020 3,62x
Capitalization 21 517 M
Chart CERNER CORPORATION
Duration : Period :
Cerner Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CERNER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 75,48  $
Last Close Price 67,58  $
Spread / Highest target 25,8%
Spread / Average Target 11,7%
Spread / Lowest Target -9,74%
EPS Revisions
Managers
NameTitle
Brent Shafer Chairman & Chief Executive Officer
Michael R. Nill Chief Operating Officer
Marc G. Naughton Chief Financial Officer & Executive Vice President
Doug Dickey Senior Director & Chief Medical Officer
Gerald E. Bisbee Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CERNER CORPORATION28.93%21 517
THERMO FISHER SCIENTIFIC26.74%113 591
DANAHER CORPORATION34.52%99 513
INTUITIVE SURGICAL, INC.8.17%59 705
BOSTON SCIENTIFIC CORPORATION8.18%53 253
EDWARDS LIFESCIENCES CORPORATION48.27%47 232